The Mitochondria-Immune Axis: Why SS-31, NAD+, TA1 — and Now MOTS-c — Might Be the Most Overlooked Peptide Stack for Total Body Resilience
We’re seeing a new class of chronic health issues that don’t show up on basic labs — unexplained fatigue, low resilience, brain fog, recurring sore throats, gut dysfunction, hormonal burnout, and even immune system “glitches” like overreactions or underperformance. The frustrating part? These symptoms often go untreated or misdiagnosed because the root cause is invisible to standard medicine: mitochondrial dysfunction, chronic inflammation, and immune imbalance. This is research of a peptide-based protocol designed to target the underlying cellular dysfunction, not just mask symptoms. This isn’t a hype stack — it’s a science-backed strategy built on what we now know about how mitochondrial health directly impacts immune resilience, inflammation regulation, energy production, and even tissue repair. The three heavy hitters in this protocol are SS-31 (Elamipretide), NAD+, and Thymosin Alpha-1 (TA1) — and when used together, they create a biological synergy that most people would be...
